Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis.
Y Miyazaki, … , P F Piguet, P Vassalli
Y Miyazaki, … , P F Piguet, P Vassalli
Published July 1, 1995
Citation Information: J Clin Invest. 1995;96(1):250-259. https://doi.org/10.1172/JCI118029.
View: Text | PDF
Research Article Article has an altmetric score of 12

Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis.

  • Text
  • PDF
Abstract

The murine TNF-alpha gene was expressed under the control of the human surfactant protein SP-C promoter in transgenic mice. A number of the SP-C TNF-alpha mice died at birth or after a few weeks with very severe lung lesions. Surviving mice transmitted a pulmonary disease to their offspring, the severity and evolution of which was related to the level of TNF-alpha mRNA in the lung; TNF-alpha RNA was detected in alveolar epithelium, presumably in type II epithelial cells. In a longitudinal study of two independent mouse lines, pulmonary pathology, at 1-2 mo of age, consisted of a leukocytic alveolitis with a predominance of T lymphocytes. Leukocyte infiltration was associated with endothelial changes and increased levels of mRNA for the endothelial adhesion molecule VCAM-1. In the following months, alveolar spaces enlarged in association with thickening of the alveolar walls due to an accumulation of desmin-containing fibroblasts, collagen fibers, and lymphocytes. Alveolar surfaces were lined by regenerating type II epithelial cells, and alveolar spaces contained desquamating epithelial cells in places. Platelet trapping in the damaged alveolar capillaries was observed. Pulmonary pathology in the SP-C TNF-alpha mice bears a striking resemblance to human idiopathic pulmonary fibrosis, in which increased expression of TNF-alpha in type II epithelial cells has also been noted. These mice provide a valuable animal model for understanding the pathogenesis of pulmonary fibrosis and exploring possible therapeutic approaches.

Authors

Y Miyazaki, K Araki, C Vesin, I Garcia, Y Kapanci, J A Whitsett, P F Piguet, P Vassalli

×

Total citations by year

Year: 2025 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1992 1991 1986 Total
Citations: 1 5 6 12 4 11 2 6 9 8 4 10 8 20 6 10 12 7 18 10 10 9 23 16 17 16 13 13 5 2 1 1 295
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2021 (12)

Title and authors Publication Year
Beneficial impact of cathelicidin on hypersensitivity pneumonitis treatment—In vivo studies
MK Lemieszek, K Sawa-Wejksza, M Golec, J Dutkiewicz, J Zwoliński, J Milanowski, C Staab-Weijnitz
PloS one 2021
Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19
M Kiener, N Roldan, C Machahua, A Sengupta, T Geiser, OT Guenat, M Funke-Chambour, N Hobi, MK Julio
Frontiers in Medicine 2021
Tumor microenvironment and radioresistance
T Suwa, M Kobayashi, JM Nam, H Harada
Experimental & molecular medicine 2021
Twist1 in T Lymphocytes Augments Kidney Fibrosis after Ureteral Obstruction
J Ren, X Lu, R Griffiths, J Privratsky, S Crowley
2021
Pulmonary Complications of Pediatric Hematopoietic Cell Transplantation. A National Institutes of Health Workshop Summary
RF Tamburro, KR Cooke, SM Davies, S Goldfarb, JS Hagood, A Srinivasan, ME Steiner, D Stokes, N DiFronzo, N El-Kassar, N Shelburne, A Natarajan, N Aggarwal, M Boeckh, GS Cheng, A Waghmare, J Hill, L Broglie, J Chien, S Cross, J McArthur, CN Duncan, L Lehmann, C Ullrich, B Fisher, G Hildebrandt, RR Jenq, KM Mahadeo, S Jodele, J Kiley, V Maholmes, B Moore, G Yanik, L Nogee, S Paczesny, C Rowan, KR Schultz, K Williams, J Woods, MS Zinter
Annals of the American Thoracic Society 2021
Molecular and Clinical Features of EGFR-TKI-Associated Lung Injury
T Ohmori, T Yamaoka, K Ando, S Kusumoto, Y Kishino, R Manabe, H Sagara
International journal of molecular sciences 2021
Preclinical MRI to quantify pulmonary disease severity and trajectories in poorly characterized mouse models: A pedagogical example using data from novel transgenic models of lung fibrosis
IR Stecker, MS Freeman, S Sitaraman, CS Hall, PJ Niedbalski, AJ Hendricks, EP Martin, TE Weaver, ZI Cleveland
2021
Mesenchymal Stromal Cells for the Treatment of Interstitial Lung Disease in Children: A Look from Pediatric and Pediatric Surgeon Viewpoints
G Pelizzo, S Silvestro, MA Avanzini, G Zuccotti, E Mazzon, V Calcaterra
Cells 2021
Interstitial Score and Concentrations of IL-4Rα, PAR-2, and MMP-7 in Bronchoalveolar Lavage Fluid Could Be Useful Markers for Distinguishing Idiopathic Interstitial Pneumonias
M Bruzova, M Pavlova, R Matej, M Sterclova, M Vasakova
Diagnostics 2021
Distinct TNF-alpha and HLA polymorphisms associate with fibrotic and non-fibrotic subtypes of hypersensitivity pneumonitis
C Freitas, B Lima, N Melo, P Mota, H Novais-Bastos, H Alves, O Sokhatska, L Delgado, A Morais
2021
Twist1 in T Lymphocytes Augments Kidney Fibrosis after Ureteral Obstruction
J Ren, X Lu, R Griffiths, JR Privratsky, SD Crowley
2021
Increased sensitivity to TNF‑α promotes keloid fibroblast hyperproliferation by activating the NF‑κB, JNK and p38 MAPK pathways
Q Li, F Cheng, K Zhou, L Fang, J Wu, Q Xia, Y Cen, J Chen, Y Qing
Experimental and therapeutic medicine 2021

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 policy sources
Referenced in 5 patents
Referenced in 1 clinical guideline sources
68 readers on Mendeley
1 readers on CiteULike
See more details